- What is Foundayo?
- Indications and Benefits of Foundayo
- Drug Information Table
- How Does Foundayo Work?
- Dosage
- Foundayo vs. Other Weight Loss Treatments
- Foundayo Usage Guide
- Side Effects
- Missed Dose
- Overdose
- Storage Information
- Warnings
- Contraindications
- Interactions
- Alternatives
- Cost & Ordering Information
- How to Order?
- Frequently Asked Questions
- Disclaimer
- Price Match Guarantee
What is Foundayo?
Foundayo (orforglipron) is an FDA-prescription drug to help adults with obesity, or adults with overweight and also have at least one weight-related condition, reduce body weight and keep it off long term.
It is used together with a reduced-calorie diet and increased physical activity. It is usually prescribed to adults who need extra support with weight loss when lifestyle changes alone are not enough.
Foundayo is not recommended to be used with other drugs in the same class. It works by helping control appetite and food intake.
It is not known if it is safe for children. Patients may also look into factors like foundayo tablet cost when considering treatment options, but use should always be based on medical advice and individual health needs.
Indications and Benefits of Foundayo
FDA-approved indications
- Reduce excess body weight in adults with obesity
- Reduce body weight in adults with overweight and at least one weight-related condition.
- Help maintain weight loss when used with a reduced-calorie diet and increased physical activity.
Key clinical benefits
- Average weight loss of about 12.4 percent at the highest dose in clinical trials
- Up to 11.1 percent body weight reduction over 72 weeks in some studies
- Around 54.5 percent of patients lost at least 10 percent of body weight at higher doses
- Associated with improvements in waist size, blood pressure, and cholesterol levels
Off-label use
- There are no widely established off-label uses at this time; it is mainly used for weight management as approved by the FDA.
Drug Information Table
| Category | Details |
| Brand Name | Foundayo |
| Generic Name | Orforglipron |
| Medication Class | GLP-1 receptor agonist |
| Primary Use | Helps reduce body weight and maintain weight loss in adults with obesity, or adults with overweight and at least one weight-related condition. Used with a reduced-calorie diet and increased physical activity. |
| Additional Uses / Off-Label | No approved off-label uses listed. Should not be used with other GLP-1 receptor agonists. |
| Available Form | Tablet |
| Method of Administration | Taken by mouth once daily, with or without food. Swallow whole. Do not crush or chew. |
| Available Dosage Strengths | 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg |
| Dosing Frequency | Once daily. Dose is increased slowly based on response. |
| Storage Instructions | Store at room temperature 20°C to 25°C (68°F to 77°F). Keep in the original bottle and carton to protect from light. Close the bottle tightly after each use. |
| Pregnancy & Breastfeeding | Pregnancy: may harm the unborn baby. Do not use during pregnancy. Breastfeeding: not recommended during treatment. |
| Major Drug Interactions | Strong CYP3A4 inhibitors may require a dose limit. Strong CYP3A4 inducers may reduce the effect. Avoid use with some liver transport inhibitors. May reduce the effect of oral birth control pills. Insulin or sulfonylureas may increase the risk of low blood sugar. |
| Manufacturer | Lilly USA, LLC (Eli Lilly and Company) |
How Does Foundayo Work?
Foundayo works by acting on natural signals in your body that help control appetite and food intake. It targets a pathway called the GLP-1 receptor, which plays a role in how your brain and gut respond to food.
Foundayo helps you feel full sooner, reduces hunger, and can lower how much you eat during the day. It also slows how quickly food leaves your stomach, which helps you stay satisfied longer after meals.
This effect builds over time as you continue taking it daily. Many people may start to notice changes in appetite within the first few weeks, while weight loss becomes more noticeable over several weeks to months with continued use.
Foundayo is taken once daily, and its effects last throughout the day when used as directed.
Dosage
Foundayo comes in multiple tablet strengths to support gradual dose increases. These include 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. This step-up approach helps the body adjust and lowers the chance of stomach side effects.
The dosage of Foundayo is started low and increased slowly over time to help reduce stomach-related side effects and improve tolerability.
Available dosage strengths and forms
- Oral tablets
- 0.8 mg
- 2.5 mg
- 5.5 mg
- 9 mg
- 14.5 mg
- 17.2 mg
Dosage Chart
| Condition | Starting Dose | Dose Escalation | Maintenance Dose | Maximum Dose |
| Weight management in adults with obesity or overweight | 0.8 mg once daily for at least 30 days | Increase to 2.5 mg once daily after at least 30 days, then to 5.5 mg once daily after at least 30 days. Dose may be increased further to 9 mg, 14.5 mg, and up to 17.2 mg once daily based on response and tolerance, with at least 30 days between each increase | Individualized based on response and tolerance | 17.2 mg once daily |
Foundayo vs. Other Weight Loss Treatments
| Drug Name | Drug Class | Form | Dosing Frequency | Primary Use | Key Difference from Foundayo |
| Foundayo | GLP-1 receptor agonist | Oral tablet | Once daily | Long-term weight management in adults with obesity, or overweight, with at least one weight-related condition | Oral GLP-1 tablet taken once daily, with or without food |
| Zepbound | GIP and GLP-1 receptor agonist | Subcutaneous injection | Once weekly | Long-term weight management in adults with obesity, or overweight, with at least one weight-related condition | Weekly injection instead of a daily tablet |
| Wegovy | GLP-1 receptor agonist | Subcutaneous injection | Once weekly | Long-term weight management in adults with obesity, or overweight with at least one weight-related condition; also approved for some cardiovascular risk reduction uses in certain adults with obesity/overweight | Weekly injection instead of a daily tablet |
| Saxenda | GLP-1 receptor agonist | Subcutaneous injection pen | Once daily | Long-term weight management in adults with obesity, or overweight with at least one weight-related condition, and in certain adolescents with obesity | Daily injection rather than a daily tablet |
| Contrave | Naltrexone and bupropion combination | Extended-release tablet | Twice daily after dose escalation | Chronic weight management in adults with obesity, or overweight, with at least one weight-related condition | Oral tablet, but it is not a GLP-1 drug and is taken in divided doses |
| Qsymia | Phentermine and topiramate extended-release combination | Capsule | Once daily | Long-term weight management in adults with obesity, or overweight, with at least one weight-related condition | Oral once daily option, but it is not a GLP-1 drug |
Foundayo Usage Guide
Follow these steps to take Foundayo safely and correctly:
Step-by-step instructions
- Take Foundayo exactly as directed by your doctor
- Take it once daily, at the same time each day, to stay consistent
- You can take it with or without food
- Swallow the tablet whole with water
- Do not break, crush, or chew the tablet
- Follow a reduced-calorie diet and stay active while using it
Important things to avoid
- Do not take more than one tablet per day
- Do not use it with other GLP-1 receptor agonists
- Avoid stopping and restarting without guidance if you missed several days
How to know it is working?
- You may feel less hungry or full sooner after eating
- You may notice gradual weight loss over time
- Results usually improve when combined with diet and physical activity
Foundayo is a tablet and not an injection, so no preparation or self-injection steps are needed.
Side Effects
| Common Side Effects (frequency not specified in FDA label) | Serious Side Effects (seek immediate medical attention) |
| Nausea | Pancreatitis with severe stomach pain that may spread to the back |
| Constipation | Severe stomach problems that do not go away |
| Diarrhea | Dehydration that may lead to kidney problems |
| Vomiting | Low blood sugar, especially when used with insulin or sulfonylureas |
| Indigestion | Serious allergic reactions such as swelling of the face, lips, tongue, or throat, or trouble breathing |
| Stomach pain | Vision changes in patients with type 2 diabetes |
| Headache | Gallbladder problems with symptoms like upper stomach pain, fever, or yellowing of skin or eyes |
| Swollen belly | Risk of food entering the lungs during surgery or procedures with anesthesia |
| Feeling tired | |
| Belching | |
| Heartburn | |
| Gas | |
| Hair loss |
Missed Dose
If you miss a daily dose of Foundayo, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time.
Do not take two doses at once. If you miss taking Foundayo for 7 days or more in a row, call your healthcare provider to discuss restarting.
Overdose
Signs of a Foundayo overdose may include severe nausea, vomiting, or other unusual symptoms. If you suspect an overdose, call Poison Control at 1-800-222-1222 or go to the nearest emergency room right away.
There is no specific antidote for Foundayo overdose. Medical staff will treat symptoms and monitor you as needed.
Storage Information
Store Foundayo at room temperature between 20°C and 25°C (68°F and 77°F). This applies before and after opening the bottle. Keep the tablets in the original bottle and carton to protect them from light.
Always close the bottle tightly after each use.
Keep Foundayo in a dry place and avoid exposure to excess moisture. Do not freeze the tablets. There is no specific time limit after opening as long as the tablets are stored properly in the original container.
Do not use expired tablets. Dispose of unused or expired medication safely, following local pharmacy or waste disposal guidelines.
Warnings
Precautions
- Acute pancreatitis: Foundayo has been linked to inflammation of the pancreas. Patients should stop taking it and seek medical care if they develop severe and persistent stomach pain, which may spread to the back and may occur with or without nausea or vomiting.
- Severe gastrointestinal reactions: Some patients may experience serious stomach-related problems. Foundayo is not recommended in patients with severe delayed stomach emptying.
- Acute kidney injury: Loss of fluids due to nausea, vomiting, or diarrhea may lead to kidney problems. Patients should stay hydrated and report ongoing symptoms.
- Hypoglycemia: Foundayo can lower blood sugar levels. The risk is higher when used with insulin or sulfonylureas, so patients should be aware of symptoms like dizziness, sweating, or confusion.
- Hypersensitivity reactions: Serious allergic reactions, including swelling of the face or throat and difficulty breathing, may occur. Immediate medical attention is required if these happen.
- Diabetic retinopathy complications: Rapid changes in blood sugar may worsen existing eye conditions in patients with type 2 diabetes. Monitoring is recommended.
- Acute gallbladder disease: Gallstones or inflammation of the gallbladder may occur. Patients should report symptoms such as upper stomach pain, fever, or yellowing of the skin or eyes.
- Pulmonary aspiration risk: Foundayo slows stomach emptying, which may increase the risk of food entering the lungs during surgery or procedures with anesthesia. Patients should inform their care team before any procedure.
Patients Who Need Extra Caution
- Patients with a history of thyroid cancer or endocrine conditions
- Patients with pancreas, kidney, or severe stomach disorders
- Patients with type 2 diabetes, especially those with eye complications
- Patients taking insulin or sulfonylureas
- Patients planning surgery or procedures requiring anesthesia
Monitoring Requirements
- Monitor for signs of thyroid tumors and pancreatitis
- Check kidney function in patients with fluid loss
- Monitor blood sugar levels, especially in patients with diabetes
- Observe for changes in vision in patients with diabetic eye disease
- Evaluate for gallbladder symptoms if they develop
Use Foundayo under medical supervision and report any concerning symptoms promptly.
FDA Black Box Warning: Risk of Thyroid C-Cell Tumors
| Foundayo carries a boxed warning about the potential risk of thyroid C-cell tumors. This warning is based on findings seen with similar drugs in animal studies, where thyroid tumors were observed. It is not known if this risk applies to humans. Foundayo should not be used in patients who have a personal or family history of medullary thyroid carcinoma or in those with Multiple Endocrine Neoplasia syndrome type 2. Patients should be informed about possible symptoms of thyroid tumors, such as a lump or swelling in the neck, trouble swallowing, shortness of breath, or a persistent hoarse voice. They should seek medical attention if these symptoms occur. |
Contraindications
Do not use Foundayo in the following situations:
- Personal or family history of medullary thyroid carcinoma (MTC): Foundayo is not recommended because similar drugs have been linked to thyroid tumors in studies. This may increase the risk in patients with this history.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): Patients with this condition already have a higher risk of thyroid tumors, so using Foundayo may add to that risk.
- Serious hypersensitivity to orforglipron or any ingredient in Foundayo: This includes past reactions such as severe rash, swelling, trouble breathing, or life-threatening allergic reactions like anaphylaxis or angioedema.
These patients should not take Foundayo under any circumstances.
Interactions
| Drug / Substance | What Happens | What to Do |
| Strong CYP3A4 inhibitors (e.g., ketoconazole) | Increase Foundayo levels in the body, which may raise the risk of side effects | Limit Foundayo dose to a maximum of 9 mg daily; avoid if also an OATP1B inhibitor |
| Strong CYP3A4 inhibitors with OATP1B inhibition (e.g., ritonavir) | Can significantly increase Foundayo levels | Avoid using together |
| Strong CYP3A4 inducers (e.g., rifampin) | Lower Foundayo levels reduce its effectiveness | Avoid using together |
| Moderate CYP3A4 inducers (e.g., carbamazepine) | May reduce how well Foundayo works | Monitor response and adjust dose if needed |
| Simvastatin | Foundayo increases simvastatin levels, which may raise the risk of side effects | Do not exceed 20 mg of simvastatin daily |
| Insulin or sulfonylureas | May increase the risk of low blood sugar | Dose adjustment may be needed; monitor blood sugar closely |
| Oral hormonal contraceptives | Foundayo may reduce its absorption and effectiveness | Use a non-oral or barrier method for 30 days after starting or increasing the dose |
| Other oral medications | Slowed stomach emptying may affect how these drugs are absorbed | Monitor for changes in effect and adjust if needed |
Alternatives
| Drug Name | Generic Name | Drug Class | Key Difference from Foundayo | Best For (patient profile) |
| Wegovy | Semaglutide | GLP-1 receptor agonist | Wegovy is a once-weekly injection, while Foundayo is a once daily oral tablet. Wegovy is also approved for some additional uses, including lowering cardiovascular risk in certain adults and use in certain pediatric patients. | Adults who prefer a weekly GLP-1 injection or who may also meet label criteria for other approved Wegovy uses |
| Zepbound | Tirzepatide | GIP and GLP-1 receptor agonist | Zepbound acts on two receptors instead of one and is given as a once-weekly injection. Foundayo is a GLP-1 only oral tablet taken once daily. | Adults who are candidates for a weekly injectable option and want a dual pathway treatment |
| Saxenda | Liraglutide | GLP-1 receptor agonist | Saxenda is a once-daily injection, while Foundayo is a once-daily tablet taken by mouth. | Adults who are candidates for GLP-1 treatment but use an injectable daily routine |
| Contrave | Naltrexone / Bupropion | Opioid antagonist and aminoketone antidepressant combination | Contrave is a non-GLP-1 oral tablet and works through a different pathway than Foundayo. | Adults who need a non-GLP-1 oral option for chronic weight management |
| Xenical | Orlistat | Gastrointestinal lipase inhibitor | Xenical works in the digestive tract to reduce fat absorption and is taken with meals, while Foundayo works through the GLP-1 pathway and is taken once daily. | Adults who want a non-GLP-1 option that works by reducing dietary fat absorption |
Cost & Ordering Information
Buy Foundayo Through Buy Canadian Insulin
Buy Canadian Insulin helps patients access Foundayo through participating pharmacy partners.
Pricing may vary depending on product strength, quantity selected, supplier availability, and participating pharmacy partner pricing policies.
Some patients may find pricing through participating pharmacy partners that differs from certain U.S. retail pharmacy prices.
Available services may include:
- Pricing options based on quantity selected
- Prescription processing through participating pharmacy partners
- Shipping options available across eligible U.S. delivery locations
- Ordering support through phone, email, or live chat
- Multiple quantity options depending on prescription authorization and supplier availability
A valid prescription is required for Foundayo.
Prescription medications require review and approval by a licensed healthcare professional and pharmacist before dispensing, where applicable.
Shipping timelines may vary depending on prescription review requirements, inventory availability, destination location, and carrier services.
Prescription Medications Discounts and Coupons
Eligible first-time customers may use coupon code FIRST10 during checkout for qualifying orders, subject to current promotional terms and conditions.
Ordering Information
Have a prescription?
Patients may explore available Foundayo prescription options through participating pharmacy partners.
Available ordering features may include:
- Pricing options based on quantity selected
- Multiple quantity options depending on prescription details
- Shipping options with tracking availability when provided by the carrier
- Customer support assistance through phone, email, or live chat
- Online and phone ordering availability
Customer Support & Business Information
For questions regarding prescription processing, product availability, shipping timelines, or account support, contact Buy Canadian Insulin customer support:
Phone: 1-888-525-1815
Fax: 1-888-234-1275
Email: info@buycanadianinsulin.com
Customer Support Hours:
Monday-Friday: 7am – 10pm CST
Saturday & Sunday: 9am – 5pm CST
Business Address:
Buy Canadian Insulin
1026 Manitoba Avenue, Suite 1001
Selkirk, MB R1A 4M2
Canada
About Buy Canadian Insulin Services
Buy Canadian Insulin works with participating pharmacy partners to help patients access prescription medications and related healthcare products.
Product availability, pricing, and shipping timelines may vary depending on supplier inventory, participating pharmacy partner availability, and destination location.
Some prescription orders may be fulfilled through licensed pharmacy partners located in Canada or other international fulfillment locations depending on product availability.
Orders are packaged according to pharmacy handling and shipping procedures.
How to Order?
|
Have a prescription?
Order Foundayo online today and enjoy a host of benefits, including: |
Frequently Asked Questions
Buying Foundayo from Canada
FDA-Prescription, Off-Label Information, and Limitations
Dosage & Administration
Adverse Reactions
Food & Drug Interactions
Storage & Travel
Drug Comparison
Disclaimer
Buy Canadian Insulin provides educational information about medications and health conditions for informational purposes only. This content is not intended to replace professional medical advice, diagnosis, or treatment. Prescription medications require valid prescription review and processing through participating pharmacy partners. Product availability, pricing, and shipping timelines may vary. Consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
